Literature DB >> 26537167

Effect of Fibrin Formulation on Initial Strength of Tendon Repair and Migration of Bone Marrow Stromal Cells in Vitro.

Kosuke Uehara1, Chunfeng Zhao1, Anne Gingery1, Andrew R Thoreson1, Kai-Nan An1, Peter C Amadio1.   

Abstract

BACKGROUND: Cell-based tissue engineering techniques have been introduced to improve tendon repair outcomes. The purpose of this study was to determine optimal concentrations of fibrinogen and thrombin for use as a scaffold to deliver stromal cells to the tendon repair site.
METHODS: Lacerated flexor digitorum profundus tendons from forty canine forepaws underwent simulated repair with fibrin gel interposition. The tendons were divided into five groups with different ratios of fibrinogen (mg/mL) to thrombin (NIH units/mL) used to form the gels. These ratios, which ranged from those found in normal hemostasis to those used clinically as adhesives, were 5:25 (the physiological ratio, used as a control), 40:250 (a low adhesive concentration of fibrinogen and a low adhesive concentration of thrombin [low-low group]), 80:250 (high-low group), 40:500 (low-high group), and 80:500 (high-high group). The failure load and tensile stiffness at time zero, compressive stiffness of the fibrin gel, and cell viability and migration were evaluated.
RESULTS: The failure loads of the high-low and high-high groups were significantly higher than that of the control group. The tensile stiffness of the high-high group was significantly higher than that of the control group. The high-low and high-high groups had significantly higher compressive stiffness than the other groups. While there was no significant difference among the groups regarding cell viability, the cells in the control, low-low, and low-high gels were spindle-shaped whereas those in the high-low and high-high groups were rounded. Cells migrated across scratch gaps within twenty-four hours in the control, low-low, and low-high groups, but not in the high-low and high-high groups.
CONCLUSIONS: Higher concentrations of fibrinogen resulted in stronger and stiffer gels, but the strength was far less than that of a tendon suture and these gels were associated with a more rounded cell morphology and reduced cell migration. Therefore, lower concentrations of fibrinogen should be used if a fibrin gel is employed to deliver cells for tendon repair. CLINICAL RELEVANCE: Concentrations of fibrinogen lower than those used in fibrin glue may be more appropriate if fibrin is employed to create a cell delivery matrix for tendon repair.
Copyright © 2015 by The Journal of Bone and Joint Surgery, Incorporated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26537167      PMCID: PMC4625644          DOI: 10.2106/JBJS.O.00292

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  36 in total

1.  Matrix elasticity directs stem cell lineage specification.

Authors:  Adam J Engler; Shamik Sen; H Lee Sweeney; Dennis E Discher
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

2.  Flexor tendon repairs: the impact of fiberwire on grasping and locking core sutures.

Authors:  Brian Miller; Seth D Dodds; Adam deMars; Niko Zagoreas; Thanapong Waitayawinyu; Thomas E Trumble
Journal:  J Hand Surg Am       Date:  2007 May-Jun       Impact factor: 2.230

Review 3.  Fibrin as a delivery system for therapeutic drugs and biomolecules.

Authors:  Ailish Breen; Timothy O'Brien; Abhay Pandit
Journal:  Tissue Eng Part B Rev       Date:  2009-06       Impact factor: 6.389

4.  Fibrin glue injection method with diluted thrombin for refractory postoperative digestive fistula.

Authors:  Masahiro Murakami; Takeshi Tono; Kazuyuki Okada; Hiroshi Yano; Takushi Monden
Journal:  Am J Surg       Date:  2009-05-01       Impact factor: 2.565

5.  Effects of synovial interposition on healing in a canine tendon explant culture model.

Authors:  Jun Ikeda; Chunfeng Zhao; Steven L Moran; Kai-Nan An; Peter C Amadio
Journal:  J Hand Surg Am       Date:  2010-06-11       Impact factor: 2.230

6.  The effects of bone marrow stromal cell transplants on tendon healing in vitro.

Authors:  Chunfeng Zhao; Hsiao-Feng Chieh; Karim Bakri; Jun Ikeda; Yu-Long Sun; Steven L Moran; Kai-Nan An; Peter C Amadio
Journal:  Med Eng Phys       Date:  2009-09-06       Impact factor: 2.242

7.  Cell therapy for spinal cord repair: optimization of biologic scaffolds for survival and neural differentiation of human bone marrow stromal cells.

Authors:  Mercedes Zurita; Laura Otero; Concepción Aguayo; Celia Bonilla; Edgar Ferreira; Avelino Parajón; Jesús Vaquero
Journal:  Cytotherapy       Date:  2010-07       Impact factor: 5.414

8.  Zone-II flexor tendon repair: a randomized prospective trial of active place-and-hold therapy compared with passive motion therapy.

Authors:  Thomas E Trumble; Nicholas B Vedder; John G Seiler; Douglas P Hanel; Edward Diao; Sarah Pettrone
Journal:  J Bone Joint Surg Am       Date:  2010-06       Impact factor: 5.284

9.  Tissue engineering of tendons and ligaments by human bone marrow stromal cells in a liquid fibrin matrix in immunodeficient rats: results of a histologic study.

Authors:  Stefan Hankemeier; Martijn van Griensven; Marco Ezechieli; Tanja Barkhausen; Matthew Austin; Michael Jagodzinski; Rupert Meller; Ulrich Bosch; Christian Krettek; Johannes Zeichen
Journal:  Arch Orthop Trauma Surg       Date:  2007-06-14       Impact factor: 3.067

Review 10.  Cell phenotypic variation in normal and damaged tendons.

Authors:  Peter D Clegg; Sandra Strassburg; Roger K Smith
Journal:  Int J Exp Pathol       Date:  2007-08       Impact factor: 1.925

View more
  4 in total

1.  Cell and Biologic-Based Treatment of Flexor Tendon Injuries.

Authors:  Stephen W Linderman; Richard H Gelberman; Stavros Thomopoulos; Hua Shen
Journal:  Oper Tech Orthop       Date:  2016-09

2.  The effect of fibrin formulation on cell migration in an in vitro tendon repair model.

Authors:  Kosuke Uehara; Chunfeng Zhao; Anne Gingery; Andrew R Thoreson; Kai-Nan An; Peter C Amadio
Journal:  J Orthop Sci       Date:  2020-08-16       Impact factor: 1.805

3.  Assessment of Migration of Human MSCs through Fibrin Hydrogels as a Tool for Formulation Optimisation.

Authors:  Nasseem Salam; Sotiria Toumpaniari; Piergiorgio Gentile; Ana Marina Ferreira; Kenneth Dalgarno; Simon Partridge
Journal:  Materials (Basel)       Date:  2018-09-19       Impact factor: 3.623

4.  A novel engineered purified exosome product patch for tendon healing: An explant in an ex vivo model.

Authors:  Guidong Shi; Yicun Wang; Zhanwen Wang; Andrew R Thoreson; Daniel S Jacobson; Peter C Amadio; Atta Behfar; Steven L Moran; Chunfeng Zhao
Journal:  J Orthop Res       Date:  2020-10-14       Impact factor: 3.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.